The Prescription: 1st March 2022 Issue
Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
News Archive
EDITOR'S EMULSION

Pyush Misra

Warm Greetings!!!

Welcome to yet another most pleasant Reading of our newsletter.

It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.

Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief

DOSE OF THE DAY

The Ayushman Bharat Digital Mission can be seen as a digital highway connecting various players across the healthcare ecosystem.

It will transform the country's health landscape and ensure ease of living for patients & health-care service providers.

Dr. Mansukh Mandaviya
Minister of Health and Family Welfare
Govt. Of India

 

Sponsor

FB FB Tw SUBSCRIBE
Patient Safety Capsules

Ayush hospitals and dispensaries register over 20% growth in 10 years

New Delhi, February 26, 2022: The number of Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homoeopathy and Sowa Rigpa (Ayush) hospitals in the country has grown almost 21 per cent in the last 10 years, from 3,193 hospitals in 2011 to 3,859 hospitals 2020, with majority of the hospitals catering to Ayurveda treatment.

Read More
Two of the four proposals for Pharma MSME cluster programme rejected: Ministry of MSME

New Delhi, February 23, 2022: The Central Government has rejected two out of the four proposals received under the programme it has announced for pharma Micro, Small and Medium Enterprises (MSMEs) clusters, designed to be developed with 70% support from the Government of India.

Read More
Drug Laws & Policy Injections
QCI certifies 22 siddha and 4 ayurveda healers of Tamil Nadu as authentic practitioners of traditional healing systemsChennai, February 24, 2022: Twenty two folk healers practicing traditional method of treatments using siddha medicines and four healers using ayurvedic medicines and techniques in Pollachi Taluk in Coimbatore district in Tamil Nadu have been certified by the Quality Council of India (QCI) as authentic folk healers of traditional systems of treatment.Read More
ICMR set to team up with domestic manufacturers to accelerate indigenous production of medical devices & diagnostic products Mumbai, February 24, 2022: In a bid to reduce India’s dependency on imports for its medical device needs, the Indian Council of Medical Re-search (ICMR) is set to join hands with domestic manufacturers to accelerate development of medical devices and diagnostic products and their scale-up, thus catalyzing their commercialization for public use.Read More
Rare disease treatment policy in India: accessibility, affordability and acceptability are keyFebruary 28, 2022: Each year, the last day of February is commemorated as International Rare Disease Day. The proclamation of World Rare Disease Day in 2008 served to galvanize, coordinate and strengthen global efforts to raise awareness of the issues facing patients with rare diseases and to bring together all stakeholders. Read More
SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adultsNew Delhi, February 27, 2022: Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its COVID-19 vaccine Covovax as a booster dose in adults, official sources said on Sunday. Read More
Ayushman Bharat: Cabinet gives nod to Rs 1,600-crore outlay for 5 yearsNew Delhi, February 27, 2022: The Union Cabinet on Saturday approved nationwide roll-out of the Ayushman Bharat Digital Mission (ABDM) with an outlay of Rs 1,600 crore for five years. Read More
Health ministry launches ICMR/DHR Policy on Biomedical Innovation and EntrepreneurshipMumbai, February 25, 2022: The Union health ministry has launched ICMR/ DHR Policy on Biomedical Innovation and Entrepreneurship for medical professionals, scientists and technologists at medical, dental, para-medical institutes. Read More
Pharma Injections
Govt support to stem cell research helped establishment of facilities in 40 institutions: MinisterNew Delhi, February 28, 2022: In an effort to support the research and development in regenerative medicine in the country, the Government of India has helped setting up state-of-the-art stem cell research facilities in 40 premier health research and educational institutions.Read More
Scientists identify mechanisms associated with severe COVID-19 blood clottingFebruary 26, 2022: After studying blood samples from 244 patients hospitalized with COVID-19, a group of researchers, including those working at the National Institutes of Health, have identified “rogue antibodies” that correlate with severe illness and may help explain the mechanisms associated with severe blood clotting.Read More
Tracing the rise of medical technology in India: megatrends February 26, 2022: India’s healthcare and medical device industry has witnessed a significant evolution over the past decade. Technology has equipped us to revolutionize healthcare as we know it, improving patient outcomes and raising the bar for quality care. Read More
Industry seeks govt intervention to address container shortage at inland container depots Mumbai, February 22, 2022: The drug industry has urged the central government to engage with shipping lines to address shortage of containers at Inland Container Depots (ICDs), leading to rise in transportation costs for inland manufacturers, thus impacting the supply chain of pharmaceutical products.Read More
Department of Commerce working with CDSCO for promotion of newer products for exports New Delhi, February 22, 2022: The Department of Commerce (DoC) is working with the drug regulator for the promotion of newer products such as gene therapy, biosimilars, and specialty drugs to drive the next phase of growth in exports, simultaneously working on setting up footprints in under-penetrated international markets.Read More
Study finds ayurvedic drug BGR-34 effective in diabetes management February 28, 2022: In a boost to Indian’s traditional medicine therapies, a study has shown that ayurvedic drug BGR-34 can help lower blood sugar level within 12 weeks as well as exert a powerful anti-oxidant action to prevent diabetic complications.Read More
Drug Dopes
Centre asks states, UTs to allow relaxation of Covid curbsNew Delhi, February 25, 2022: The Union Home Ministry on Friday asked states and union territories to consider relaxing Covid curbs for social, sports, entertainment, academic and religious events as well as night curfew hours in view of the substantial decline in the number of cases. Issuing COVID-19 guidelines for March, Union Home Secretary Ajay Bhalla also suggested the implementation of a risk assessment based approach on the opening of economic activities as suggested by the Union Health Ministry recently. Read More
India and Japan to strengthen ties in pharma and healthcareBengaluru, March 1, 2022: India and Japan will strengthen ties in pharma and healthcare and will chip in expertise and experience. Seven Japanese companies with deep-tech solutions in the fields of medicine, healthcare and drones among others are looking to further penetrate into the country.Read More
CBN asks exporters, importers of narcotic drugs to register with ICEGATE portal for faster customs clearance Mumbai, February 28, 2022: To speed up the customs clearance of import and export of narcotic drugs, psychotropic and controlled substances, the Central Bureau of Narcotics (CBN) under Union finance ministry has directed the exporters and importers to register on the ICEGATE portal, to avail the benefits of e-Sanchit services of the customs department. Read More
Pharma exporters hail removal of export curb on Covid drugs-remdesivir, amphotericin-B, enoxaparin, IVIG Mumbai, February 26, 2022: The Director General of Foreign Trade (DGFT) has lifted restriction on export of remdesivir injection and API, amphotericin-B injections, enoxaparin (formulation and API), and intravenous immunoglobulin (IVIG) with immediate effect thus bringing cheers to drug exporters. Read More
In less than a month, nearly 54% of eligible teens are now fully enrolled New Delhi, February 26, 2022: In less than a month from 15 to 17 -year -olds to become eligible for a second Covaxin infection, every two adoles-cents are fully admitted to Delhi. As of Wednesday, 9,13,362 adolescents had been given the first dose of Covaxin and 5,44,861 the second dose. Read More
E-Healthcare maintains a strong presence among healthcareFebruary 23, 2022: Unexplained changes and the outcome of COVID-19 disease cannot be exaggerated. The ripple effects of change after the disease were further explained in the conference. Every health system is looking for a tool or device to ensure that people are safe, well cared for and monitored while making sure they are not under the influence of the disease. . E-healthcare is the most efficient, easy to adapt, and the right result to achieve. Read More
National Injections
Delhi High Court notifies IPR Division Rules, 2022 New Delhi, March 1, 2022: The High Court of Delhi has notified the Intellectual Property Rights Division Rules, 2022, which will replace the erstwhile Intellectual Property Appellate Board (IPAB), among others, in a relief to the industry including pharmaceutical players who are looking for an appellate court for remedy to their grievances in the Intellectual Property-related disputes.Read More
Karnataka gets four of the six genome sequencing labs approved by DBTBengaluru, February 26, 2022: The Department of Biotechnology (DBT) has approved the inclusion of six private genomic sequencing labs into the Indian SARS-CoV-2 Genomics Consortium (INSACOG). The network of labs is identified by the government to sequence the coronavirus disease (Covid) samples. Four of these labs are from Karnataka.Read More
TN SPC extends deadline for intimating change of residential addresses to council office to March 31 Chennai, February 26, 2022: Owing to poor response to the advertisements given by the Tamil Nadu State Pharmacy Council (TN SPC) asking the registered pharmacists to intimate their change of addresses to the council office for preparing a fresh electoral roll, the council has extended the deadline for filing details by one more month to March 31 from February 28, 2022. Read More
Pvt Hosp fined for denial of standards Thiruvananthapuram, March 1, 2022: The district medical officer (DMO) has imposed a fine at a private hospital for embezzling medical expenses of Rs 1.42 lakh from a patient who had been removed from a Covid cell. Read More
Researchers call for clarity about the ‘health problem’ February 19, 2022: A new review of models used around the world to assess, diagnose, research, and manage mental health problems reveals a number of avenues that exist. Read More
India released from RT-PCR test before leaving New Delhi, February 21, 2022: PeoFull training in India does not currently require a poor RT PCR test report on return from the UAE to the country. They can upload their travel certificate of India. Read More
Global Injections
UK to cut all Covid stocks next weekLondon, February 26, 2022: The British government confirmed on Saturday that people with Covid-19 will not be forced to separate themselves starting next week, as plans for a “stay with Covid” are seen testing for returned coronavirus. Read More
Two Drug Manufacturers Seek Approval of New COVID-19 VaccineFebruary 24, 2022: Drugmakers Sanofi and GlaxoSmithKline said Wednesday that they will seek authorization for a new COVID-19 vaccine after clinical trials showed a high level of protection, according to The Associated Press. Read More

Targeting Ticks and Lyme Disease With Gene Editing February 23, 2022: We hear a lot about the scourges of mosquitoes as they spread malaria, dengue fever, Zika, and other illnesses, but they're certainly not the only tiny vector out there spreading disease.Read More

Medicago’s plant-based COVID vaccine, Covifenz, wins first approval February 24, 2022: As Sanofi and GlaxoSmithKline's COVID-19 vaccine finally heads to regulators, another shot using GSK’s pandemic adjuvant has taken home its first global approval.Read More

GSK launches trade secrets case against former employee February 17, 2022: Following Pfizer and AbbVie, GlaxoSmithKline is the latest drug major to launch a trade secrets case against an ex-staffer. For GSK, the case comes after several other high-profile trade secrets suits that ended in settlements.Read More

Moderna taps Thermo Fisher for 15-year mRNA production pact for COVID vaccines and more Febraury 23, 2022: In the third year of the pandemic, mRNA specialist Moderna is marshaling one of its tried-and-true manu-facturing partners to lock up production of its COVID shot for years to come.Read More

PSAIIF PILL

Expert panel recommends permission for manufacturing and marketing of a few more anti-diabetic FDCs

New Delhi, February 24, 2022: The over $2 billion Indian diabetes market may see entry of a few fixed dose combinations (FDCs) in various strengths to be launched by various drug manufacturers in the near future, as a panel has recommended the drug regulator for their approval in due course.

Read More

Commerce ministry relaxes most of restrictions on exports

New Delhi, March 1, 2022: The ministry of commerce and industry has stated that it has relaxed most of the restrictions or prohibitions imposed by the Ministry on the products including drug formulations, diagnostic kits and medical devices to manage Covid-19 pandemic in the recent months due to drastic increase in production of these items and adequate stock availability.Read More

Frequently Asked Questions

Which New Moms Are at Highest Risk for Postpartum Depression?
First-time moms and new mothers of twins may be among those at greatest risk of postpartum depression symptoms, a large new study suggests. Postpartum depression is a common illness. In the United States alone, about one in eight women report depression symptoms soon after giving birth, according to the U.S. Centers for Disease Control and Prevention. Read More>>>

SUBSCRIBER'S SYMPTOM

Childhood Trauma May Influence Vaccine Hesitancy: Study

February 22, 2022: People who remain hesitant to get a COVID-19 vaccine may feel that way because of an association with traumatic events in childhood that undermine trust, including domestic violence, substance abuse in the home, or neglect, a new study suggests.Read More

Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services

First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.Read More

Upcoming Events
UpComing Events
Laughter Dose
Blog Addicts
Ms. Aarohi, Haridwar It's awesome, really, I can't say enough about how well it's tailored to cover healthcare news from all around..
Ms. Shahina Saba, KolkataThank you for all of your hard work and dedication in publishing such an updated newsletter.
Mr. Jagdish Tyagi, Gaya I love the approachable format and the articles that PSAI choses to feature in their Newsletter. Good work, Keep it up!
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSAIIF may not be held responsible for any article published in The Prescription.